Seoul National University Bundang Hospital

Medicine & Life Sciences

1. Korea 100%
2. Neoplasms 51%
3. Therapeutics 43%
4. Stomach Neoplasms 41%
5. Survival 40%
6. Confidence Intervals 37%
7. Republic of Korea 37%
8. Stroke 32%
9. Cohort Studies 30%
10. Recurrence 30%
11. Population 30%
12. Mortality 28%
13. Odds Ratio 26%
14. Safety 26%
15. Magnetic Resonance Imaging 25%
16. Multicenter Studies 25%
17. Child 25%
18. Incidence 25%
19. Eye 24%
20. Helicobacter pylori 24%
21. Tomography 24%
22. Breast Neoplasms 24%
23. Elderly 24%
24. Mutation 23%
25. Non-Small Cell Lung Carcinoma 22%
26. Genes 22%
27. Serum 22%
28. Neoplasm Metastasis 22%
29. Drug Therapy 21%
30. Seoul 21%
31. Randomized Controlled Trials 21%
32. Registries 21%
33. Lung 20%
34. Stents 20%
35. Retrospective Studies 20%
36. Hepatocellular Carcinoma 20%
37. Prostatic Neoplasms 18%
38. Liver 18%
39. Hip 18%
40. Prospective Studies 17%
41. Kidney 17%
42. Thigh 16%
43. Gastrectomy 16%
44. Genotype 16%
45. Stomach 15%
46. Biopsy 15%
47. Lung Neoplasms 15%
48. Myocardial Infarction 15%
49. Meta-Analysis 15%
50. Colorectal Neoplasms 15%
51. Multivariate Analysis 15%
52. Prostatectomy 15%
53. Bone and Bones 15%
54. Pain 15%
55. Transplants 15%
56. Type 2 Diabetes Mellitus 14%
57. Wounds and Injuries 14%
58. Control Groups 14%
59. Lymph Nodes 14%
60. Spine 14%
61. Body Mass Index 13%
62. Muscles 13%
63. Pediatrics 13%
64. Propensity Score 13%
65. Hemorrhage 13%
66. Guidelines 13%
67. Coronary Artery Disease 12%
68. Regression Analysis 12%
69. Injections 12%
70. Thorax 12%
71. Asthma 12%
72. Laparoscopy 12%
73. Glucose 12%
74. Brain 12%
75. Blood Pressure 12%
76. Rotator Cuff 12%
77. Chronic Renal Insufficiency 12%
78. University Hospitals 12%
79. Skin 11%
80. Logistic Models 11%
81. Biomarkers 11%
82. Radiotherapy 11%
83. Nutrition Surveys 11%
84. Quality of Life 11%
85. Progression-Free Survival 11%
86. Renal Cell Carcinoma 11%
87. Pathologic Constriction 11%
88. Obstructive Sleep Apnea 11%
89. Osteotomy 11%
90. Positron-Emission Tomography 11%
91. Blood Vessels 11%
92. Pharmaceutical Preparations 11%
93. Survival Rate 11%
94. Knee 11%
95. Adenocarcinoma 10%
96. Carcinoma 10%
97. Infections 10%
98. Ultrasonography 10%
99. Placebos 10%
100. Equipment and Supplies 10%